1. Reduced Immune Response to Inactivated Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine in a Cohort of Immunocompromised Patients in Chile. (7th March 2022) Authors: Balcells, M Elvira; Le Corre, Nicole; Durán, Josefina; Ceballos, María Elena; Vizcaya, Cecilia; Mondaca, Sebastián; Dib, Martín; Rabagliati, Ricardo; Sarmiento, Mauricio; Burgos, Paula I; Espinoza, Manuel; Ferrés, Marcela; Martinez-Valdebenito, Constanza; Ruiz-Tagle, Cinthya; Ortiz, Catalina; Ros... Journal: Clinical infectious diseases Issue: Volume 75:Number 1(2022) Page Start: e594 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Safety and Immunogenicity of an Inactivated Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine in a Subgroup of Healthy Adults in Chile. (19th September 2021) Authors: Bueno, Susan M; Abarca, Katia; González, Pablo A; Gálvez, Nicolás M S; Soto, Jorge A; Duarte, Luisa F; Schultz, Bárbara M; Pacheco, Gaspar A; González, Liliana A; Vázquez, Yaneisi; Ríos, Mariana; Melo-González, Felipe; Rivera-Pérez, Daniela; Iturriaga, Carolina; Urzúa, Marcela; Domínguez, Angélic... Journal: Clinical infectious diseases Issue: Volume 75:Number 1(2022) Page Start: e792 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗